| Advantages | They model hair disorders such as alopecia and provide a reliable platform for safe and effective evaluation of hair growth therapies. |
| Species | Human |
| Product Type | iPSC-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Skin |
| Disease | Dermatitis, Atopic, Phototoxicity, Hair loss, etc |
| Generation Process | Human skin organoids derived from pluripotent stem cells (hPSCs) are generated using optimized differentiation protocols, yielding mature, hair-bearing skin structures suitable for research applications. |
| Organoid Characterization | Mature skin organoids display a multilayered architecture comprising epidermis, dermis, and subcutaneous tissue, recapitulating the structural organization of native skin. They incorporate diverse cell lineages, including fibroblasts, melanocytes, hair follicle-associated cells, and adipocytes. |
| Applications | This human organoid platform ensures high biological relevance, reproducibility, and ethical integrity, supporting the transition toward sustainable, animal-free research in dermatology and hair biology. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.